Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 31 | SFEBES2013 | Next issue

Society for Endocrinology BES 2013

Poster Presentations

Obesity, diabetes, metabolism and cardiovascular

Association of calcium-sensing receptor polymorphisms with vascular calcification and glucose homeostasis in renal transplant recipients
1Academic Endocrine Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK; 2Institute of Physiology, University of Zurich, Zurich, Switzerland.
ea0031p177
Testosterone stimulates cholesterol efflux and metabolism in human macrophages via liver X receptor
1University of Sheffield, Sheffield, UK; 2Barnsley Hospital NHS Foundation Trust, Barnsley, UK.
ea0031p178
FGF21 action on human adipose tissue compromised by reduced [beta]Klotho and FGFR1 expression in type 2 diabetes mellitus
1Division of Metabolic and Vascular Health, Warwick Medical School, University of Warwick, Coventry, UK; 2Warwickshire Institute for the Study of Diabetes Endocrinology and Metabolism (WISDEM), University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.
ea0031p179
Vitamin B12 and folate imbalance induces cholesterol synthesis and endoplasmic reticulum stress in human adipocytes
1Division of Metabolic and Vascular Health, University of Warwick, Warwick, UK; 2Systems Biology Centre, University of Warwick, Warwick, UK.
ea0031p182
Acute effects of co-infusion of peptide YY (3[ndash]36) and glucagon-like peptide-1 on insulin secretion and insulin sensitivity
1Division of Diabetes, Endocrinology and Metabolism, Imperial College London, Hammersmith Hospital, London, UK; 2Division of Endocrinology and Metabolic Medicine, Department of Medicine, Imperial College London, St Mary’s Hospital, London, UK.
ea0031p187
Human abdominal subcutaneous adipocytes as an active source of LpPLA2, influenced by fat depot and metabolic state, with LpPLA2 converting LDL into more potent atherogenic Ox-LDL, in vitro
1Division of Metabolic and Vascular Health, Warwick Medical School, University of Warwick, Coventry, UK; 2Biomarkers Research Program, Biochemistry Department, College of Science, King Saud University, Riyadh, Saudi Arabia; 3Human Metabolism Research Unit, WISDEM, UHCW, Coventry, UK.
ea0031p188
The role of glucocorticoid metabolism in bile acid homeostasis
Endocrinology Unit, Centre for Cardiovascular Science, Edinburgh University, QMRI, Edinburgh, UK.
ea0031p189
Testosterone differentially regulates lipid and glucose metabolism in visceral and subcutaneous fat in the testicular feminised mouse
1University of Sheffield, Sheffield, UK; 2Barnsley Hospital NHS Foundation Trust, Barnsley, UK; 3Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
ea0031p190
Novel inositol pyrophosphate and insulin sensitivity in response to muscle contraction in glucose intolerant humans
1University of Westminster, London, UK; 2Brighton University, Brighton, UK; 3King’s College Hospital, London, UK.
ea0031p191
Augurin stimulates food intake in male Wistar rats
1Imperial College, London, UK; 2University of Roehampton, London, UK.
ea0031p192
Replication of genome wide association-validated loci for type 2 diabetes mellitus in the Saudi Arabian population
1King Saud University, Riyadh, Saudi Arabia; 2University of South Hampton, South Hampton, UK; 3Warwick Medical School, University of Warwick, Coventry, UK; 4University of Edinburgh, Edinburgh, UK.
ea0031p195
Cellular consequences for insulin signal transduction of the naturally occurring AKT2 p.Glu17Lys mutation
Metabolic Research Laboratories, Institute of Metabolic Science, University of Cambridge, Cambridge, Cambridgeshire, UK.
ea0031p196
Inflammatory markers in diabetic foot and impact of vitamin D deficiency
1Medwin Hospital, Hyderabad, Andhrapradesh, India; 2MKCG Medical College, Berhampur, Orissa, India; 3Roland Institute of Pharmaceutical Sciences, Berhampur, Orissa, India.
ea0031p198
The possible involvement of the receptor for advanced glycation end products in vascular senescence in diabetes
1Tokyo Medical and Dental University, Tokyo, Japan; 2Imperial College London, London, UK.
ea0031p199
Vitamin D and insulin resistance: no association in healthy overweight people at high risk of cardiovascular disease
1Regional Centre For Endocrinology and Diabetes, Royal Victoria Hospital, Belfast, UK; 2Nutrition and Metabolism Group, Centre for Public Health, Queen’s University Belfast, Belfast, UK.
ea0031p202
Altered mitochondrial dynamics in obesity: redressing the balance through bariatric surgery?
1Division of Metabolic and Vascular Health, Warwick Medical School, University of Warwick, Coventry, UK; 2University of Warwick and George Eliot Hospital, Warwick Medical School, Coventry, UK.
ea0031p204
Irisin as a central regulator in energy homeostasis?
1Division of Metabolic and Vascular Health, Warwick Medical School, University of Warwick, Coventry, UK; 2Warwickshire Insitute for the Study of Diabetes, Endocrinology and Metabolsim, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK; 3Division of Reproductive Health, Warwick Medical School, University of Warwick, Coventry, UK; 4Department of Pathology, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.
ea0031p205
Ileal interposition with diverted sleeve gastrectomy for treatment of type 2 diabetes
1Medwin Hospital, Hyderabad, Andhrapradesh, India; 2Kirloskar Hospital, Hyderabad, Andhrapradesh, India.
ea0031p206
Polycystic ovary syndrome has no independent effect on vascular, inflammatory or thrombotic markers when matched for obesity
1Hull York Medical School, Hull, UK; 2Hull and East Yorkshire NHS Trust, Hull, UK; 3University of Hull, Hull, UK; 4Leeds Institute for Genetics, Health and Therapeutics, University of Leeds, Leeds, UK.
ea0031p207
Leptin in serum and vitreous humor, and retinal ob mRNA, in human diabetes
1Obs Gyn, IWK Health Centre, Dalhousie University, Halifax, Canada; 2Division of Endocrinology, VG Hospital, Halifax, Canada; 3Ophthalmology and Visual Sciences, Dalhousie University, Halifax, Canada.
ea0031p208
Maternal B12 insufficiency predicts neonate's metabolic risk factors
1University of Warwick, Warwick, UK; 2Heartlands Hospital, Birmingham, UK; 3George Eliot Hospital, Nuneaton, UK.
ea0031p210
The public distress domain of quality of life correlates directly and independently with BMI in pre-operative morbidly obese patients awaiting metabolic surgery
1Warwick Medical School, Warwickshire Institute for Diabetes, Endocrinology and Metabolism, The University of Warwick, Coventry, West Midlands, UK; 2Division of General Surgery, University Hospitals of Coventry and Warwickshire (NHS Trust), Coventry, West Midlands, UK; 3Warwickshire Institute for Diabetes, Endocrinology and Metabolism, University Hospitals of Coventry and Warwickshire (NHS Trust), Coventry, West Midlands, UK.
ea0031p212
Pregestational BMI predicts neonatal hypoglycemia in women with gestational diabetes
1Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, Uttar Pradesh, India; 2Indraprastha Apollo Hospital, New Delhi, India.
ea0031p213
Effectiveness of bariatric surgery in women with and without polycystic ovarian syndrome
1Salford Royal NHS Foundation Trust, Salford, UK; 2The University of Manchester, Manchester, UK.
ea0031p214
Prevalence of vitamin D insufficiency in severely obese patients seeking bariatric surgery
1Department of Medicine, University College London, London, UK; 2UCL Institute of Cardiovascular Science, London, UK; 3UCLH Centre for Weight Loss, Metabolic and Endocrine Surgery, London, UK.
ea0031p216
Appetite regulation during a 6-month military tour to Afghanistan
1Imperial College London, London, UK; 2Institute of Naval Medicine, Alverstoke, UK; 3Royal Centre for Defence Medicine, Birmingham, UK.
ea0031p217
Weight loss after bariatric surgery in women of childbearing age
1Salford Royal NHS Foundation Trust and University Teaching Hospital, Salford, UK; 2The University of Manchester, Manchester, UK.
ea0031p218
Hepatic 11[beta]-hydroxysteroid dehydrogenase type 1 is elevated following weight loss secondary to bariatric surgery
1Education and Research Centre, St Vincent’s University Hospital and St Columcille’s Hospital, Dublin, Ireland; 2Centre for Endocrinology, Diabetes and Metabolism, Institute of Biomedical Research, University of Birmingham, Birmingham, UK; 3Department of Endocrinology, Adelaide and Meath Hospital, Tallaght l, Dublin, Ireland.
ea0031p220
Brown adipose tissue identification in an adult human using IDEAL MRI
1University of Warwick, Coventry, UK; 2University Hospitals of Coventry and Warwickshire, Coventry, UK.
ea0031p221
Vitamin D supplementation as influenced by diabetic therapies
1King Saud University, Riyadh, Saudi Arabia; 2King Abdulaziz University Hospital, Riyadh, Saudi Arabia; 3Warwick Medical School, Warwick University, Coventry, UK.
ea0031p222
Association of the incidence of type 1 diabetes with markers of infection and antibiotic susceptibility at country level
1Diabetes and Endocrine Centre, Mater Dei Hospital, Malta; 2University of Malta Medical School, Msida, Malta.
ea0031p223
A pilot study of 25-hydroxy vitamin D level in type 2 diabetes mellitus with diabetic retinopathy
Endocrine, 7 Metabolism Unit, Ain Shams University, Cairo, Egypt.
ea0031p224
Non-alcoholic fatty liver disease in patients attending the National Severe Insulin Resistance Service
1Metabolic Research Laboratories, University of Cambridge, Cambridge, UK; 2Wolfson Brain Imaging Centre, University of Cambridge, Cambridge, UK; 3Wolfson Department of Diabetes and Endocrinology, Addenbrookes Hospital, Cambridge, UK; 4Department of Radiology, University of Cambridge, Cambridge, UK; 5Department of Radiology, Addenbrookes Hospital, Cambridge, UK; 6Department of Medicine, Addenbrookees Hospital, Cambridge, UK.
ea0031p225
A study of serum osteocalcin level in women with gestational diabetes mellitus
Endocrine, 7 Metabolism Unit, Ain Shams University, Cairo, Egypt.
ea0031p226
Short term calorie restriction: effects on endocrine markers of nutritional status
Defence Institute of Physiology and Allied Sciences, Delhi, India.
ea0031p227
Hypogonadism in males with type 2 diabetes mellitus
Federal Medical Centre, Lokoja, Kogi State, Nigeria.
ea0031p229
Obesity-related hypogonadotrophic hypogonadism: recovery of normal pituitary[ndash]gonadal axis function following bariatric surgery
1Royal Victoria Infirmary,Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK; 2South Tyneside Hospital, South Shields, UK.
ea0031p230
Risk assessment of adult residents in ile-ife, South-Western Nigeria for type 2 diabetes mellitus
Obafemi Awolowo University Teaching Hospitals’ Complex, Ile-Ife, Osun State, Nigeria.
ea0031p231
Impaired iron status in severely obese bariatric surgery candidates is multifactorial
1Department of Medicine, University College London, London, UK; 2UCL Institute of Cardiovascular Science, London, UK; 3UCLH Centre of Weight Loss, Metabolic and Endocrine Surgery, London, UK.
ea0031p234
Prevalence and associated risks for metabolic syndrome in nigerians with type 2 diabetes mellitus
1Ladoke Akintola University of Technology Teaching Hospital, Osogbo, Osun, Nigeria; 2Obafemi Awolowo University Teaching Hospital, Ile-Ife, Osun, Nigeria; 3Obafemi Awolowo University, Ile-Ife, Osun, Nigeria.
ea0031p237
Preoperative characteristics of morbidly obese patients who achieved at least 50% excess weight loss post-metabolic Surgery
1Warwickshire Institute for Diabetes, Endocrinology and Metabolism, Warwick Medical School, The University of Warwick, Coventry, West Midlands, UK; 2Division of General Surgery, University Hospitals of Coventry and Warwickshire (Nhs Trust), Coventry, West Midlands, UK; 3Warwickshire Institute for Diabetes, Endocrinology and Metabolism, University Hospitals of Coventry and Warwickshire (NHS Trust), Coventry, West Midlands, UK.
ea0031p239
Unusual case of hypoglycaemia in diabetic patient
Glan Clwyd Hospital, Rhyl, UK.
ea0031p241
withdrawing insulin in a young person
1Sandwell, West Bromwich, UK; 2Good Hope, Suttoncoldfield, UK.
ea0031p242